Twenty years ago, Avalere Health set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to listen to our experts discuss the hot topics that you need to track.
Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.
Tune into the third episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the future of RSV among older adults.
Tune into the second episode in our miniseries focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss RSV prevention products currently in development, specifically maternal immunizations and pediatric vaccines.
Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.
Tune into the third episode in the Avalere Health Essential Voice podcast series focused on Agency decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs) by considering how potential policy and market catalysts 3 to 5 years out may help stakeholders think through opportunities and risks at key decision points ranging from early in development to implications for Part D.
Tune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS's evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclonal antibodies for Alzheimer's disease as an example.
Tune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.
In the third and final episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share insights on disparities in kidney care. Listen to previous episodes in this series: Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems Exploring the Kidney Care Environment, Part II, Policy and Payment Trends
In the second episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share their perspective on policy and payment trends. Listen to previous episodes in this series: Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems
In this episode of Avalere Health Essential Voice, we kick off our miniseries focused on the evolving kidney care landscape.
In this episode of the Avalere Health Essential Voice, we welcome leaders from the National Alliance of State & Territorial AIDS Directors (NASTAD) to discuss state HIV policies and barriers to ending the HIV epidemic in the US.
In this episode of the Avalere Health Essential Voice, we welcome Carl Schmid, Executive Director at the HIV + Hepatitis Policy Institute, to commemorate World AIDS Day on December 1.
In this episode of Avalere Health Essential Voice, our experts continue their discussion on channel strategy development for bringing a drug to market. Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i Tune into Part 2 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-ii
In this episode of Avalere Health Essential Voice, our experts welcome leaders from Gilead Sciences and Jazz Pharmaceuticals to discuss channel distribution strategy. Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
In this episode of Avalere Health Essential Voice, the fifth and final in our Medicare Part D miniseries, our experts discuss the Center for Medicare & Medicaid Innovation (CMMI) and where we can anticipate some activity in the coming year, particularly as it relates to the Part D program.
In this episode of Avalere Health Essential Voice, the fourth in our Medicare Part D miniseries, our experts discuss key elements of the legislative process including budget neutrality and congressional scoring.
In this episode of Avalere Health Essential Voice, the third in our Medicare Part D miniseries, our experts discuss policy changes and the impact on market access.
In this episode of Avalere Health Essential Voice, the second in our Medicare Part D miniseries, our experts discuss how health plans make decisions within Part D.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the need for patient support in cell and gene therapies and the ways in which various stakeholders provide it.
In this episode of Avalere Health Essential Voice, the first in our Medicare Part D miniseries, our experts discuss Part D trends and pressures in the evolving drug pricing environment.
In this episode of Avalere Health Essential Voice, our experts discuss what they expect to see from a legislative perspective this fall on Capitol Hill.
In this episode of Avalere Health Essential Voice, our experts discuss the forthcoming debate around the coverage gap for individuals residing in states that have not participated in Medicaid expansion.
In this episode of Avalere Health Essential Voice, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the use of third-party logistics companies for distribution, warehousing, and fulfillment in biopharma.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss Huntington’s Disease through the lens of its symptoms, challenges, and potential treatment.
In this episode of Start Your Day with Avalere, Chris Johnson of Landmark Health joins us to discuss his organization’s experience as an early participant in CMMI’s Direct Contracting payment model.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the challenges surrounding cell and gene therapies from both the patient and payer perspective.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a study on the impact of Medicaid expansion on coverage and care for women of reproductive age.
In this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the final session in our 3-part series on infusing the patient perspective into value assessment.
In this episode of the Avalere Health Essential Voice Disease Education Series, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the state of oncology care from a provider and a patient perspective as we continue to look at the impact of COVID-19 and prepare for post-pandemic realities.
In this episode of Start Your Day with Avalere, our policy experts discuss healthcare price transparency efforts and the anticipated impact of making previously confidential pricing information public.
In this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the second of a three-part series on infusing the patient perspective into value assessment.
In this episode of Avalere Health Essential Voice, experts from our Market Access practice discuss major takeaways from the 2021 National Comprehensive Cancer Network annual conference.
In this episode of the Avalere Health Essential Voice Start Your Day with Avalere series, our experts kick off a three-part series on incorporating the patient perspective in value assessment.
In this episode of our Avalere Health Essential Voice Disease Education series, experts from our Center for Healthcare Transformation discuss the prevalence of malnutrition, its impact on the healthcare system, and the Avalere-led quality improvement initiative created to address it.
Tune in to the replay of our webinar, Understanding Shifting Insurance Coverage Impacts to hear Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers. As a result of the COVID-19 pandemic and associated economic downturn, millions of Americans have lost employer-sponsored insurance and have either enrolled in publicly subsidized coverage or become uninsured. Healthcare stakeholders will need to adapt to these changes and consider site-of-care policies and reimbursement, evolution of benefit structure, patient and provider access and support programs, and cost-sharing implications. Key Topics Coverage shift causes and trends Care delivery impacts (physicians and health plan coverage of services) New variables for consumer plan choices Payer responses and policy change Patient access and support Ancillary support strategies Potential congressional action affecting coverage This webinar was recorded on March 17, 2021.
In this episode of Avalere Health Essential Voice, President and CEO of Tivity Health, Richard Ashworth, joins us to discuss the impact of COVID-19 on seniors’ health and wellbeing, and how this population’s attitude toward the COVID vaccine continues to evolve.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent analysis of birth centers as an enhanced, evidence-based care model in CMS’s Strong Start initiative.
Tune in to the replay of our webinar, COVID-19: Lessons Learned and the Path Forward to hear Avalere’s panel of policy, public health, and regulatory experts discuss the challenges, opportunities, and key milestones to watch. As we near the 1-year COVID-19 pandemic declaration, new issues and questions emerge for healthcare industry stakeholders. COVID-19 has significantly altered traditional approaches. It has also accelerated change and further exposed challenges within our system. During this webinar, Avalere experts will discuss how the pandemic has transformed healthcare and what these changes will mean going forward. Key Topics Exploring FDA pathway developments Understanding COVID-19 vaccine challenges Examining overall vaccine market implications Advancing evidence generation strategies Elevating the importance of health equity This webinar was recorded on February 24, 2021.
In this episode of Avalere Health Essential Voice focused on disease education, experts from our Market Access practice discuss support programs designed for rare disease patients, caregivers, and providers, particularly in light of the continued impact of COVID-19 on the patient population.
In this episode of Avalere Health Essential Voice, we welcome nutrition experts to discuss the use of telehealth in providing nutrition care during the pandemic, as well as future barriers and opportunities in virtual care.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on how food labeling affects consumption. This episode is based on findings from an article published on PubMed.gov: Smart Food Policy for Healthy Food Labeling: Leading With Taste, Not Healthiness, to Shift Consumption and Enjoyment of Healthy Foods
In this episode of Avalere Health Essential Voice, our experts discuss recent research focused on patients who received CAR T-cell therapy for large B-cell lymphoma (LBCL) using Medicare fee-for-service claims data.
On January 7, 2021, Sarah Butler led 4 panel discussions exploring the key healthcare questions for the upcoming year and evidence-based strategies for life sciences companies, health plans, and providers to overcome potential access barriers and improve health outcomes. Download the 2021 Avalere Healthcare Industry Outlook document. The archived video of the webinar will be available soon. Key Topics Navigating the post-election policy landscape, including the COVID-19 pandemic, health disparities, drug pricing, and access to healthcare coverage Addressing patient affordability, drug pricing, the role of Center for Medicare & Medicaid Innovation Using data and innovative care models to address healthcare disparities, public health issues, and the consequences of delayed and deferred care Understanding the emerging COVID-19 vaccines and therapeutics marketplace and the role of the Food & Drug Administration
In this episode of Avalere Health Essential Voice, experts from nutrition service organizations discuss the growing importance of medically tailored meals (MTM) in addressing food insecurity and poor health for medically complex individuals.
In this episode of Get the Facts on COVID-19, Avalere vaccines experts discuss state distribution plans for existing and future COVID-19 vaccines.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on disparities in the health development of young children.
In this episode of Start Your Day with Avalere, our experts discuss how telehealth has evolved during the pandemic and where they believe the sector is headed.
In this episode of Start Your Day with Avalere, our policy experts discuss the Most Favored Nation (MFN) drug pricing model due to begin on January 1.
In Part 2 of this episode focused on social determinants of health (SDOH), Avalere experts discuss how life sciences companies are recognizing the importance of SDOH data and its impact on intervention development.
In this episode of Start Your Day with Avalere, our experts discuss the mechanisms behind CMS’s direct contracting payment model and its future outlook.
© 2020-2025 Ivy Podcast Discovery LLC
